Approximately 1,092 cartons of Omnipaque (iohexol) Injection, 180mgI/mL, are being recalled because a defect was found in the 20 mL single-dose glass vials. This defect can compromise the container's seal and may lead to the presence of glass particles or a lack of sterility in the medication. Consumers should be aware that this affects 10-vial cartons of the 20 mL size, specifically from lot 14301544.
A compromised vial seal can allow bacteria to enter the medication, leading to serious infections. Additionally, the presence of glass particles in an injectable drug can cause local irritation, inflammation, or more severe complications if the particles travel through the bloodstream.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.